Because five of the seven CLL samples showed a decrease in global RNA synthesis, we used immunoblot analysis to determine the protein levels of c-MYC and histone H3, which are substrates of PIM kinases, in five CLL samples (Figure 3C). The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.